About us

Overview

Skin diseases and disorders are among the most common health problems worldwide and are associated with a considerable burden. It encompasses psychological, social and financial consequences not only on the patients, but also on their families and on society. In particular, chronic and incurable skin diseases/disorders are associated with significant morbidity in the form of physical discomfort and impairment of patients' quality of life and malignant diseases, such as carcinomas, are associated to substantial mortality.

Advances in the field of skin tissue engineering and regenerative medicine have been progressively paving the way to develop innovative therapeutics but much is yet to be achieved. Deeper understanding of the molecular mechanisms underlying these diseases/disorders can be the key to further unravel advanced therapies.

GENE2SKIN, a project financed by the Twinning initiative of the Widening programme of Horizon2020, establishes the linkage between two of best European Institutions in their fields – King’s College London, UK and Royal College of Surgeons in Ireland - and the 3B’s Research Group -University of Minho, Portugal. With these leading institutions GENE2SKIN endorses 3B’s Research Group - University of Minho to reinforce the network of collaborations within this field, establishing fruitful partnerships and improve the quality and the innovative nature of the developed research reaching excellence. This will allow taking the research of excellence to the next level by fostering the successive transfer of technology at different levels, resulting in better and safer advanced therapies for skin disorders/diseases.

CONNECT WITH US

The GENE2SKIN project has received funding from the European Union's Horizon 2020 Research and Innovation programme, under the Grant Agreement Number 692221. This website reflects only the author's view and the Commission is not responsible for any use that may be made of the information it contains.